Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy
Patients who suffer from rare skin diseases may try numerous therapies with many potential side effects before achieving remission. Livedoid vasculopathy (LV) is one such rare disease that lacks a definitive treatment as evidenced by randomized controlled trials. Although corticosteroids help reduce...
Saved in:
Main Authors: | John R. Edminister (Author), Nicole Dominiak (Author), Lorie D. Gottwald (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Livedoid vasculopathy
by: Thiago Quadrante Freitas, et al.
Published: (2018) -
Advances in anti-inflammatory therapy for Livedoid vasculopathy
by: Dan HUANG, et al.
Published: (2024) -
Livedoid vasculopathy with hyperhomocysteinemia responding to hyperbaric oxygen therapy
by: Rahul Ray, et al.
Published: (2015) -
A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
by: Anais Huot, et al.
Published: (2022) -
Ulcerative livedoid vasculopathy responding to clopidogrel
by: Elaine Kunzler, BS, et al.
Published: (2018)